One of the questions that women most frequently ask when they consider a choice of contraception is what are the side effects? Unfortunately, preventing an unwanted pregnancy can have life-threatening consequences.
For instance, Yaz and Yasmin, two of the most popular birth control pills introduced into the marketplace also happen to carry some of the highest risks of putting a woman at risk of suffering a serious side effect.
Both Yaz and Yasmin are hormonal contraceptives and the U.S. Food and Drug Administration issued an April 10, 2012 Health Warning announcing that agency officials had conducted a review and “concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills.”
Since that warning well over 10,000 Yaz and Yasmin lawsuits have been pending in courts across the country by women who are seeking compensation for medical expenses, pain and suffering and other costs incurred because they suffered blood clots.
Pharmaceutical giant Bayer Pharmaceuticals recently posted financial statements in which the company said it had paid out of $1.6 billion in the last year to settle Yaz and Yasmin lawsuits.
Other Yaz and Yasmin lawsuits have been filed by people who lost a loved one to a death caused by a blood clot, according the court records of this litigation.
In a review of allegations contained in Yaz and Yasmin blood-clotting lawsuits here are the most common serious medical problems that women who have used the contraceptives are seeking compensation over:
- Heart Attack
- Deep Vein Thrombosis
- Pulmonary Embolism
- Gall bladder Disease
- Temporary or Permanent Disability
Here is the latest outline of Yaz and Yasmin blood-clotting lawsuit legal costs incurred by Bayer as reported in its most recent financial report:
“As of October 18, 2013, Bayer had reached agreements, without admission of liability, to settle the claims of approximately 7,660 claimants in the U.S. for a total amount of about US$1.575 billion. Bayer has only been settling claims in the U.S. for venous clot injuries (deep vein thrombosis or pulmonary embolism) after a case-specific analysis of medical records on a rolling basis. Such injuries are alleged by about 2,300 of the pending unsettled claimants. Bayer will continue to consider the option of settling such individual lawsuits in the U.S. on a case-by-case basis.”
Bayer also has agreed to pay up to $24 million to settle other lawsuits that were consolidated from across the country involving allegations over gall bladder side effects, according to the court file in the litigation.